Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells

Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study

(2011) R Petrioli et al.   BRITISH JOURNAL OF CANCER

Peroxiredoxin 1 Controls Prostate Cancer Growth through Toll-Like Receptor 4-Dependent Regulation of Tumor Vasculature

(2011) J. R. Riddell et al.   CANCER RESEARCH

Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth

(2011) Z. Cai et al.   CANCER RESEARCH

Molecular Chemotherapy and Chemotherapy: A New Front against Late-Stage Hormone-Refractory Prostate Cancer

(2011) P. P. Singh et al.   CLINICAL CANCER RESEARCH

Chemotherapy-Based Treatment for Castration-Resistant Prostate Cancer

(2011) Bostjan Seruga et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer

(2011) Takeo Kosaka et al.   JOURNAL OF UROLOGY

Docetaxel-based combination therapy for castration-resistant prostate cancer

(2010) M. D. Galsky et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence

(2010) Salomé González-Reyes et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma

(2010) Sofie Claerhout et al.   INTERNATIONAL JOURNAL OF CANCER

Lipopolysaccharide directly stimulates aldosterone production via toll-like receptor 2 and toll-like receptor 4 related PI3K/Akt pathway in rat adrenal zona glomerulosa cells

(2010) Hsin-Lei Huang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance

(2010) Julien Cherfils-Vicini et al.   JOURNAL OF CLINICAL INVESTIGATION

Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer

(2010) Kim N. Chi et al.   JOURNAL OF CLINICAL ONCOLOGY

Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma

(2010) Jong-Hwan Park et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Histone Deacetylase Inhibitor Potentiates Anticancer Effect of Docetaxel via Modulation of Bcl-2 Family Proteins and Tubulin in Hormone Refractory Prostate Cancer Cells

(2010) Jung Jin Hwang et al.   JOURNAL OF UROLOGY

Phenethyl Isothiocyanate Sensitizes Androgen-Independent Human Prostate Cancer Cells to Docetaxel-Induced Apoptosis In Vitro and In Vivo

(2010) Dong Xiao et al.   PHARMACEUTICAL RESEARCH

Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells

(2009) A. C. Wang et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity

(2009) Dong Hua et al.   MOLECULAR IMMUNOLOGY

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer

(2009) M Szajnik et al.   ONCOGENE

TLR4 signaling promotes the expression of VEGF and TGFβ 1 in human prostate epithelial PC3 cells induced by lipopolysaccharide

(2008) Zengyang Pei et al.   CELLULAR IMMUNOLOGY

Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation

(2008) Qiaoling Sun et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-κB activation

(2008) Amar Hammadi et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells

(2008) R Chen et al.   ONCOGENE